Endovascular Excimer Laser-Assisted Balloon Angioplasty for Infrapopliteal Arteries in Thromboangiitis Obliterans: A Treatment for Acute-Phase TAO

Endovascular Excimer Laser-Assisted Balloon Angioplasty for Infrapopliteal Arteries in Thromboangiitis Obliterans: A Treatment for Acute-Phase TAO

BackgroundThromboangiitis obliterans (TAO, Buerger's disease) is an inflammatory and obstructive vasculopathy, which leads to limb ischemic rest pain and ulcerations in the acute stage.ObjectivesThis study aimed to assess the feasibility of excimer laser-assisted balloon angioplasty (BA) for pa...

Full description

Bibliographic Details
Main Authors:	Hongji Pu, Yihong Jiang, Zhaoyu Wu, Jiahao Lei, Jiateng Hu, Peng Qiu, Xing Zhang, Qun Huang, Xinwu Lu, Minyi Yin, Zhen Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	thromboangiitis obliterans (TAO) Buerger's disease excimer laser angioplasty endovascular treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.831340/full

Similar Items

Smoking characteristics and cessation in patients with thromboangiitis obliterans
by: C.A. Jiménez-Ruiz, et al.
Published: (2016-02-01)

Thromboangiitis obliterans (Buerger disease)
by: Jessica Seebald, BS, et al.
Published: (2015-10-01)

Thromboangiitis obliterans (Buerger's disease) - a review
by: Rafał Bogacz, et al.
Published: (2023-08-01)

True leukonychia as the presenting sign of early thromboangiitis obliterans
by: Mohammed S. Hamid, BS, et al.
Published: (2024-03-01)

Visceral bed involvement in thromboangiitis obliterans: a systematic review
by: Fakour F, et al.
Published: (2019-08-01)

Buerger’s disease or thromboangiitis obliterans: description of two cases
by: Carlo Umberto Manzini, et al.
Published: (2019-12-01)

The role of folic acid on the hyperhomocysteinemia in the Buerger′s disease (Thromboangiitis Obliterans)
by: Ali Akbar Beigi, et al.
Published: (2014-01-01)

Intestinal thromboangiitis obliterans: a case report
by: Swastik Sourav Mishra, et al.
Published: (2021-04-01)

Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
by: Alexandre Le Joncour, et al.
Published: (2018-12-01)

Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?
by: Mohareri M, et al.
Published: (2018-09-01)

Thromboangiitis Obliterans: 110 Years Old and Little Progress Made
by: Jeffrey W. Olin
Published: (2018-12-01)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
by: Sharebiani H, et al.
Published: (2020-07-01)

Assessment of T helper 17-associated cytokines in thromboangiitis obliterans
by: Keramat S, et al.
Published: (2019-09-01)

Management of Buerger's disease (thromboangiitis obliterans) of the lower limb by horizontal distraction and corticotomy by Ilizarov's technique
by: Kumar Rohit, et al.
Published: (2023-01-01)

Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
by: Chongchong Zou, et al.
Published: (2022-10-01)

Unexpected inflammation in the sympathetic ganglia in thromboangiitis obliterans: more likely sterile or infectious induced inflammation?
by: Behzad Mousazadeh, et al.
Published: (2019-07-01)

Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study
by: Zhenxing Liu, et al.
Published: (2023-12-01)

Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman
by: G. Lopalco, et al.
Published: (2015-06-01)

Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences
by: Bahare Fazeli, et al.
Published: (2021-09-01)

Segmented colon ischemia associated with thromboangiitis obliterans
by: Francisco de Saltes Collet e Silva, et al.

Psychiatric sequelae of thromboangiitis obliterans: a case report and review of the literature
by: Mahmoud A. Awara, et al.
Published: (2023-01-01)

Assessment of preprocedure difference in the supine and dependent transcutaneous tissue oxygenation to prognosticate pain relief, following chemical lumbar sympathectomy for critical limb ischemia in thromboangiitis obliterans
by: Jonathan Sadhu Reddipogu, et al.
Published: (2018-01-01)

Knowledge Mapping of Global Status and Trends for Thromboangiitis Obliterans: A Bibliometrics and Visual Analysis
by: Liu Z, et al.
Published: (2023-11-01)

Understanding Buerger's Disease: Symptoms, Diagnosis and Management Strategies
by: Adrianna Muciek, et al.
Published: (2024-12-01)

The Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011
by: Jie-Fu Zheng, et al.

Buerger’s disease: providing integrated care
by: Klein-Weigel P, et al.
Published: (2016-10-01)

Buerger’s Disease in Tehran University of Medical Sciences Hospitals: A Fifteen Years Study
by: Javad Salimi, et al.
Published: (2009-06-01)

SMOKING AND BUERGER’S DISEASE: FROM HYPOTHESES TO EVIDENCE SYNTHESIS
by: Bahare Fazeli, et al.
Published: (2022-03-01)

Buerger’s Disease in Tehran University of Medical Sciences Hospitals: A Fifteen Years Study
by: Salimi Javad, et al.
Published: (2009-10-01)

Angiogenesis induction in Buerger's disease: a disease management double-edged sword?
by: Bahare Fazeli, et al.
Published: (2019-08-01)

SURGICAL TREATMENT OF ACUTE THROMBOSIS ARTERIES OF INFRAPOPLITEAL SEGMENT
by: Y. Hupalo, et al.
Published: (2021-11-01)

Intervention of Vascular Dysplasia Caused by Different Mechanisms - Anlotinib for Right Lung Squamous Cell Carcinoma Combined with Thromboangiitis Obliterans: A Case Report and Literature Review
by: Huijuan HAO, et al.
Published: (2020-01-01)

Detection of Rickettsia Endosymbiont Bemisia Tabaci in the Amputated Limbs of Three Buerger’s Disease Patients
by: Fazeli B, et al.
Published: (2020-02-01)

Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells
by: Piotr Barć, et al.
Published: (2024-07-01)

Molecular mechanisms regulating immune responses in thromboangiitis obliterans: a comprehensive review
by: Abbas Shapouri-Moghaddam, et al.
Published: (2019-03-01)

Early Diagnosis and Intervention Are Needed for a Reasonable Prognosis of Thromboangiitis Obliterans
by: Miju Bae, et al.
Published: (2023-09-01)

Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)
by: Jorge D. Martin-Rufino, et al.
Published: (2018-05-01)

Buerger's disease: early detection to minimize progression
by: Agus Santosa, et al.
Published: (2022-12-01)

Vaso-nervorumitis: responsible for pain in Buerger’s disease?
by: Fazeli B, et al.
Published: (2019-04-01)

The Role of Gut Microbiota in Thromboangiitis Obliterans: Cohort and Mendelian Randomization Study
by: Chang Sheng, et al.
Published: (2024-07-01)